Nordhealth As Stock Price To Sales
| NORDH Stock | 40.80 0.10 0.24% |
Nordhealth AS fundamentals help investors to digest information that contributes to Nordhealth's financial success or failures. It also enables traders to predict the movement of Nordhealth Stock. The fundamental analysis module provides a way to measure Nordhealth's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nordhealth stock.
Nordhealth |
Nordhealth AS Company Price To Sales Analysis
Nordhealth's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Nordhealth Price To Sales | 60.29 X |
Most of Nordhealth's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nordhealth AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Nordhealth AS has a Price To Sales of 60 times. This is 181.74% higher than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The price to sales for all Norway stocks is notably lower than that of the firm.
Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Nordhealth Fundamentals
| Return On Equity | -0.11 | |||
| Return On Asset | -0.0552 | |||
| Profit Margin | (0.43) % | |||
| Operating Margin | (0.37) % | |||
| Current Valuation | 1.21 B | |||
| Shares Outstanding | 45.19 M | |||
| Shares Owned By Institutions | 50.31 % | |||
| Price To Book | 1.53 X | |||
| Price To Sales | 60.29 X | |||
| Revenue | 20.3 M | |||
| Gross Profit | 6.67 M | |||
| EBITDA | (369 K) | |||
| Net Income | (4.73 M) | |||
| Total Debt | 25 K | |||
| Book Value Per Share | 1.28 X | |||
| Cash Flow From Operations | 5.57 M | |||
| Earnings Per Share | (1.05) X | |||
| Target Price | 28.0 | |||
| Number Of Employees | 400 | |||
| Market Capitalization | 1.73 B | |||
| Total Asset | 125.13 M | |||
| Net Asset | 125.13 M |
About Nordhealth Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nordhealth AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nordhealth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nordhealth AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Nordhealth Stock
Nordhealth financial ratios help investors to determine whether Nordhealth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nordhealth with respect to the benefits of owning Nordhealth security.